Safety and efficacy of the combination of erlotinib and sirolimus for the treatment of metastatic renal cell carcinoma after failure of sunitinib or sorafenib

por Flaig, T W, Costa, L J, Gustafson, D L, Breaker, K, Schultz, M K, Crighton, F, Kim, F J, Drabkin, H
Publicado 2010